Recruiting

Long-term Safety Tracking of Heart Rhythm Devices

Plain-English translation of NCT00271180 on ClinicalTrials.gov ↗ · Source last updated May 2026 · Translation generated June 2026 · How we translate trials

What is this trial?

This is a long-term safety monitoring study for Medtronic heart rhythm devices—including pacemakers, defibrillators, and resynchronization devices used to treat irregular heartbeats, slow heart rate, and heart failure. Researchers will track how these devices perform over time by reviewing your medical records and follow-up visits. The goal is to make sure these devices continue working safely and effectively for patients like you.

Implanted heart devices help many people live longer, healthier lives, but doctors need to continuously monitor how well they perform over many years. This study exists to identify any potential problems early and ensure that this treatment remains safe and effective for all patients who depend on it.

Do you qualify?

You likely qualify if…

you are scheduled to receive a Medtronic heart rhythm device or have received one within the past 30 days
you have completed a previous Medtronic device research study and are willing to share that data
you have given written permission for researchers to access and use your health information
you are able to attend follow-up appointments and remain in contact with the research center

You likely don't qualify if…

you will not be able to return for follow-up visits or maintain contact with the research team
your device was implanted at a hospital or clinic that is not participating in this study
you received your device at a non-participating center and your implant details cannot be confirmed within 30 days
the research center has already enrolled the maximum number of patients for your specific device model

What participation looks like

If you enroll, researchers will monitor your implanted device through regular follow-up visits at your doctor's office, where they will review how your device is functioning and check your overall health. You'll also authorize the research team to access your medical records to track your device performance over time. There is no active treatment to receive—this is purely a monitoring and data collection study to ensure your device continues working safely.

AI-generated summary from trial data · Jun 5, 2026 · Not medical advice

Trial locations(320 sites)

United States

Birmingham, Alabama

Anchorage, Alaska

Chandler, Arizona

Jonesboro, Arkansas

Little Rock, Arkansas